Research Study Search Tool

Use our HBOC Research Search tool to find and participate in research focused on hereditaty cancers. Need assistance getting started?

Search Results: Prevention, Detection & Risk + Pancreatic Cancer + Screening & Early Detection (5 results)

Here are some research studies that may be enrolling patients like you. Please check with the study contact and your health care provider to confirm your eligibility and see if the study is right for you. Note, our search tool may not be comprehensive and additional research resources can be found here.

GENetic Education Risk Assessment and TEsting Study (GENERATE)

Prevention:
Pancreatic

GENetic Education Risk Assessment and TEsting Study (GENERATE)

The goal of the GENERATE study is to increase the uptake of genetic testing among family members of pancreatic cancer patients who carry a genetic mutation.

This study involves education about genetic testing, undergoing genetic testing for cancer risk and completion of a series of 4 sets of questionnaires.

For more information, visit the study website

A Study in Hereditary Breast and Ovarian  Cancer Families to Provide Men With  Up-To-Date Information About the Personal  Importance of Genetic Testing (GEM)

Prevention:
Pancreatic
Prostate

A Study in Hereditary Breast and Ovarian Cancer Families to Provide Men With Up-To-Date Information About the Personal Importance of Genetic Testing (GEM)

The Genetic Education for Men or GEM study, is a clinical trial evaluating educational tools for men from families in which a BRCA1/2 gene mutation has been identified. In order to identify untested men from BRCA1/2 families, we are seeking women who have received positive BRCA1/2 test results and have at least one untested male relative.

Women interested in the study should contact the project coordinator, Mary Kate Ladd, by phone at (877) 687-2720 (toll-free) or by email.

Pancreatic Cancer Early Detection Program

Prevention:
Pancreatic

Pancreatic Cancer Early Detection Program

This is a study looking at esophageal ultrasound and Magnetic Resonance Imaging (MRI) as a screening for pancreatic cancer in high risk individuals. 

BRCA Founder Outreach Study (BFOR)

Prevention:
Breast
Ovarian
Pancreatic
Prostate

BRCA Founder Outreach Study (BFOR)

BFOR is a research study looking at ways to make genetic testing easier. It offers BRCA testing at no cost to men and women age 25 or older, who have at least one Ashkenazi Jewish grandparent. The study is open to people who live in the Boston, New York, Los Angeles or Philadelphia metropolitan areas. For more information, visit the BFOR study website

PHACT Study: Population Health and Cancer Testing

Prevention:
Breast
Melanoma
Ovarian
Pancreatic
Prostate

PHACT Study: Population Health and Cancer Testing

The PHACT study offers genetic testing to women and men of Ashkenazi (Eastern European) Jewish ancestry, age 21 or older. This group is at least ten times more likely than the general population to inherit certain kinds of genetic mutations associated with cancer risk. The study is open to people who live in one of the nine Bay Area counties (Alameda, Contra Costa, Marin, Napa, San Francisco, San Mateo, Santa Clara, Solano, Sonoma).  By participating in the UCSF Population Health and Cancer Testing (PHACT) study you will be provided with a saliva collection kit from Color Genomics, a genetic laboratory. Thirty genes will be analyzed, including BRCA1 and BRCA2, to identify mutations that increase the chance of cancer in both men and women of Ashkenazi (Eastern European) Jewish ancestry and genetic counseling support will be available with every test.  For more information, visit the UCSF Center for BRCA Research. 

Additional Results on Clinicaltrials.gov: Prevention, Detection & Risk + Pancreatic Cancer + Screening & Early Detection

7 Results

Clinical Trial Official Title
NCT03250078 A Pancreatic Cancer Screening Study in High Risk Individuals
NCT03937453 A Pancreatic Cancer Screening Study in Individuals With New-Onset Diabetes Mellitus
NCT02478892 Screening for PDAC in BRCA1/2 Patients
NCT03568630 Blood Markers of Early Pancreas Cancer
NCT02206360 Pancreatic Cancer Early Detection Program
NCT03693378 A Study of IMMrayâ„¢ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups
NCT03851133 Florida Pancreas Collaborative Next Generation Biobank

FORCE:Facing Our Risk of Cancer Empowered